Our understanding about the involvement of IL-34 in IBD pathogenesis is still limited, but in recent years, some studies have highlighted the multiple effects of the cytokine on the ongoing mucosal inflammation in these disorders. Here, IL34 is linked to inflammatory bowel disease.